StockData
VSee Health, Inc. logo

VSee Health, Inc. (VSEEW) company profile

VSEEWOTCServices-Health ServicesFiscal year ends December 31Also trades as VSEE, VSEED
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02+0.00 (+8.23%)

Close on Oct 9, 2026Market cap $965.84KP/E –Yield –

About VSee Health

Services-Health Services, SIC 8000

VSee Health, Inc. provides digital healthcare and telehealth technology solutions designed to facilitate patient engagement, clinical coordination, and critical care delivery. Through its subsidiary VSee Lab, the company offers a modular, no-code and low-code telehealth software platform featuring tools for virtual patient visits, appointment scheduling, intake management, remote medical examinations, and remote patient monitoring. Through its subsidiary iDoc, the company delivers specialized tele-intensive care and virtual specialist staffing services, including neurocritical, cardiac, and pulmonary critical care coverage, as well as electronic consultations across numerous medical specialties. Its primary customers include health systems, large and small hospitals, long-term acute care facilities, and the Federal Bureau of Prisons.

The company operates primarily within the United States, serving diverse healthcare enterprises ranging from academic medical centers to micro-hospitals and federal correctional facilities. VSee Health maintains its principal executive offices in Boca Raton, Florida.

Summary of the business section of VSee Health's latest annual report, written by StockData.

Company profile

Company

Legal name
VSee Health, Inc.
Headquarters
Boca Raton, FL
Address
980 N Federal Hwy, #304 33432
Phone
(561) 672-7068
Employees
209, Dec 31, 2025
Industry
Services-Health Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
WWC, P.C., San Mateo, California

Stock & identifiers

Ticker
VSEEW
Other tickers
VSEE, VSEED
Exchange
OTC
IPO date
Nov 4, 2021
Shares outstanding
57M, Aug 12, 2026
Public float
$18.17M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Stock splits
1-for-80 reverse, Sep 24, 2026
SEC CIK
1864531
CUSIP
92919Y110
ISIN
US92919Y1102
FIGI
BBG0149QDRN4
EIN
86-2970927

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Milton ChenCo-Chief Executive Officer, Director0
Imoigele AisikuCo-Chief Executive Officer, Director3,338,000
Jerry LeonardChief Financial Officer603,109
Scott MetzgerDirector117,356
Colin P. O'SullivanDirector108,731
David L. WickershamDirector2,335,235
Kevin LowdermilkDirector108,731
Cydonii V. FairfaxDirector108,504

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusStock awardsTotalvs. prior year
Imoigele P. Aisiku
Chief Executive Officer and Chairman
$200.00K$192.00K$192.00K$584.00K+172%
Milton Chen
Former Co- Chief Executive Officer and Chairman (2)
$200.00K$100.00K–$300.00K+150%
Jerry Leonard
Senior Vice President, and Chief Financial Officer
$250.00K$200.00K$258.95K$708.95K+184%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

SPAC offering

Type
SPAC (blank check) IPO of units
Final prospectus filed
Nov 4, 2021
Offer price
$10.00
Securities offered
10,000,000
Gross proceeds
$100.00M
Exchange
Nasdaq
First trading day
Dec 31, 2021
First-day close
$9.88-1.2%
Lock-up ends (est.)
Jun 29, 2022

“We are offering 10,000,000 units at an offering price of $10.00 per unit.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“We currently have approximately 209 full-time equivalent employees and contractors, of which approximately 93 are board certified practicing physicians.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 4, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Jun 5, 2026Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 14, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Sep 29, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 5, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 22, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 11, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 30, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
May 8, 2025Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 1, 2025Late filingNotification of late filing
Sep 11, 2024Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 14, 2024Late filingNotification of late filing
Jun 28, 2024Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 28, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 24, 2024DelistingNotice of delisting from exchange (Form 25)
Jun 12, 2024Name changeName changed from DIGITAL HEALTH ACQUISITION CORP. to VSee Health, Inc.
Mar 29, 2024Late filingNotification of late filing
Nov 14, 2023Late filingNotification of late filing
Oct 13, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Sep 29, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 11, 2023Late filingNotification of late filing
May 26, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Apr 6, 2023Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Mar 31, 2023Late filingNotification of late filing
Nov 4, 2022MergerRegistration of securities for a merger or exchange offer (S-4)
Nov 4, 2021IPOInitial public offering priced (424B4 prospectus)
Nov 3, 2021ListingRegistration of securities on an exchange (Form 8-A)